Endothelial lessons

Current Vascular Pharmacology

Volumn 14, Issue 2, 2016, Pages 175-180

  Vanhoutte, Paul M ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cyclooxygenase; Endothelium dependent hyperpolarization; Endothelium derived contracting factors; Endothelium derived nitric oxide; Intact organism; Reproducibility; Serendipity; Soluble guanylyl cyclase

Indexed keywords

ENDOTHELIN 1; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; ENDOTHELIUM DERIVED RELAXING FACTOR; MATRILYSIN; NITRIC OXIDE SYNTHASE; OXYTOCIN; PROSTACYCLIN; THROMBIN; VASOPRESSIN; CARDIOVASCULAR AGENT; NITRIC OXIDE;

ARTICLE; ATHEROSCLEROSIS; CELL HETEROGENEITY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; FOOD COMPOSITION; GENE OVEREXPRESSION; HUMAN; HYPERPOLARIZATION; HYPERTENSION; NEUROTRANSMISSION; NONHUMAN; OXIDATIVE STRESS; QUALITY OF LIFE; SHEAR STRESS; SMOOTH MUSCLE RELAXATION; THROMBOCYTE AGGREGATION; VASCULAR SMOOTH MUSCLE; ANIMAL; DRUG EFFECTS; METABOLISM; PATHOLOGY; VASCULAR DISEASES; VASCULAR ENDOTHELIUM;

ANIMALS; CARDIOVASCULAR AGENTS; ENDOTHELIUM, VASCULAR; HUMANS; NITRIC OXIDE; VASCULAR DISEASES;

EID: 84958957319     PISSN: 15701611     EISSN: 18756212     Source Type: Journal    
DOI: 10.2174/1570161114666151202204754     Document Type: Article

References (91)

1. Vanhoutte PM. Cholinergic inhibition of adrenergic transmission. Fed Proc 1977; 36: 2444-49.
2. Vanhoutte PM. Inhibition by acetylcholine of adrenergic neurotransmission in vascular smooth muscle. Circ Res 1974; 34: 317- 26.
3. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-6.
4. Katusic ZS, Shepherd JT, Vanhoutte PM. Vasopressin causes endothelium- dependent relaxations of the canine basilar artery. Circ Res 1984; 55: 575-9.
5. Kim P, Lorenz RR, Sundt TM, et al. Release of endotheliumderived relaxing factor after subarachnoid hemorrhage. J Neurosurg 1989; 70: 108-14.
6. Kim P, Schini VB, Sundt Jr TM, et al. Reduced production of cyclic GMP underlies the loss of endothelium-dependent relaxations in the canine basilar artery after subarachnoid hemorrhage. Circ Res 1992; 70: 248-56.
7. Lüscher TF, Vanhoutte PM. Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension 1986; 8: 344-8.
8. Shimokawa H, Vanhoutte PM. Impaired endothelium-dependent relaxation to aggregating platelets and related vasoactive substances in porcine coronary arteries in hypercholesterolemia and in atherosclerosis. Circ Res 1989; 64: 900-14.
9. Shimokawa H, Vanhoutte PM. Hypercholesterolemia causes generalized impairment of endothelium-dependent relaxation to aggregating platelets in porcine arteries. J Am Coll Cardiol 1989; 13: 1402-8.
10. Félétou M, Vanhoutte PM. "EDHF: The Complete Story" CRC Taylor and Francis, Boca Raton 2006; 15: 1-298.
11. Vanhoutte PM. How we learned to say NO. Arteriosclerosis Thrombosis Vascular Biology 2009; 29: 1156-60.
12. Miller VM, Aarhus LL, Vanhoutte PM. Modulation of endothelium- dependent responses by chronic alterations of blood flow. Am J Physiol 1986; 251: H520-7.
13. Miller VM, Vanhoutte PM. Enhanced release of endotheliumderived factors by chronic increases in blood flow. Am J Physiol 1988; 255: H446-51.
14. Shimokawa H, Vanhoutte PM. Dietary cod-liver oil improves endothelium- dependent responses in hypercholesterolemic and atherosclerotic porcine coronary arteries. Circulation 1988; 78: 1421-30.
15. Shimokawa H, Vanhoutte PM. Dietary omega-3 fatty acids and endothelium-dependent relaxations in porcine coronary arteries. Am J Physiol 1989; 256: H968-73.
16. Gisclard V, Miller V, Vanhoutte PM. Effect of 17[-Estradiol on endothelium-dependent responses in the rabbit. J Pharmacol Exp Ther 1988; 244: 19-22.
17. De Mey JG, Claeys M, Vanhoutte PM. Endothelium-dependent inhibitory effects of acetylcholine, adenosine triphosphate, thrombin and arachidonic acid in the canine femoral artery. J Pharmacol Exp Ther 1982; 222: 166-73.
18. Busse R, Edwards G, Félétou M, et al. EDHF: Bringing the concepts together. Trends Pharmacol Sci 2002; 23: 374-80.
19. Félétou M, Vanhoutte PM. Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture). Am J Physiol Heart Circ Physiol 2006; 291: H985-1002.
20. Félétou M, Vanhoutte PM. Endothelium-dependent hyperpolarizations: past beliefs and present facts. Ann Med 2007; 39: 495-516.
21. Félétou M, Vanhoutte PM. EDHF: an update. Clin Sci 2009; 117: 139-55.
22. Nakashima M, Mombouli JV, Taylor AA, et al. Endotheliumdependent hyperpolarization caused by bradykinin in human coronary arteries. J Clin Invest 1993; 92: 2867-71.
23. Nagao T, Illiano S, Vanhoutte PM. Heterogeneous distribution of endothelium-dependent relaxations resistant to nitro-L-arginine in the arterial tree of the rat. Am J Physiol 1992; 263: 1090-4.
24. Félétou M, Vanhoutte PM. Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br J Pharmacol 1988; 93: 515-24.
25. Mombouli JV, Bissiriou I, Agboton VD, et al. Bioassay of Endothelium- Derived Hyperpolarizing Factor. Biochem Biophys Res Com 1996; 221: 484-8.
26. Félétou M, Vanhoutte PM. Endothelium-dependent hyperpolarization: no longer an F-word. J Cardiovasc Pharmacol 2013; 61: 91-2.
27. De Mey JG, Vanhoutte PM. Role of the intima in cholinergic and purinergic relaxation of isolated canine femoral arteries. J Physiol 1981; 316: 347-55.
28. De Mey JG, Vanhoutte PM. Heterogeneous behavior of the canine arterial and venous wall: importance of the endothelium. Circ Res 1982; 51: 439-47.
29. De Mey JG, Vanhoutte PM. Anoxia and endothelium dependent reactivity of the canine femoral artery. J Physiol 1983; 335: 65-74.
30. Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J 1989; 3: 2007-17.
31. Vanhoutte PM, Félétou M, Taddei S. Endothelium-dependent contractions in hypertension. B J Pharmacol 2005; 144: 449-58.
32. Vanhoutte PM, Tang EHC. Endothelium-dependent contractions: when a good guy turns bad. J Physiol 2008; 22: 5295-304.
33. Félétou M, Huang Y, Vanhoutte PM. Endothelium-mediated control of vascular tone: COX-1 and COX-2 products. Br J Pharmacol 2011; 164: 894-912.
34. Félétou M, Kohler R, Vanhoutte PM. Nitric oxide: Orchestrator of endothelium-dependent responses. Ann Med 2012; 44: 694-716.
35. Vanhoutte PM. Endothelium-dependent contractions in hypertension: when prostacyclin becomes ugly. Hypertension 2011; 57: 526-31.
36. Gräser T, Vanhoutte PM. Hypoxic contraction of canine coronary arteries: role of endothelium and cGMP. Am J Physiol 1991; 261: H1769-77.
37. Chan CKY, Mak J, Gao Y, et al. Endothelium-derived NO, but not cyclic GMP, is required for hypoxic augmentation in isolated porcine coronary arteries. Am J Physiol 2011; 301: H2313-21.
38. Gao Y, Vanhoutte PM. Tissues cIMPly do not lie---Naunyn- Schmiedeberg's. Arch Pharmacol 2014; 387(9): 901-3.
39. Rubanyi GM, Romero JC, Vanhoutte PM. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol 1986; 250: H1145-49.
40. Miller VM, Vanhoutte PM. Endothelial alpha2-adrenoceptors in canine pulmonary and systemic blood vessels. Eur J Pharmacol 1985; 118: 123-9.
41. Katusic ZS, Shepherd JT, Vanhoutte PM. Oxytocin causes endothelium- dependent relaxations of canine basilar arteries by activating V1-vasopressinergic receptors. J Pharmacol Exp Ther 1986; 236: 166-70.
42. Cohen RA, Shepherd JT, Vanhoutte PM. Inhibitory role of the endothelium in the response of isolated coronary arteries to Platelets. Science 1983; 221: 273-4.
43. Cohen RA, Shepherd JT, Vanhoutte PM. Endothelium and asymmetrical responses of the coronary arterial wall. Am J Physiol 1984; 247: H403-8.
44. Houston DS, Shepherd JT, Vanhoutte PM. Adenine nucleotides, serotonin and endothelium-dependent relaxations to platelets. Am J Physiol 1985; 248: H389-95.
45. Houston DS, Shepherd JT, Vanhoutte PM. Aggregating human platelets cause direct contraction and endothelium-dependent relaxation of isolated canine coronary arteries: role of serotonin, thromboxane A2 and adenine nucleotides. J Clin Invest 1986; 78: 539-44.
46. Shimokawa H, Aarhus AA, Vanhoutte PM. Porcine coronary arteries with regenerated endothelium have a reduced endotheliumdependent responsiveness to aggregating platelets and serotonin. Circ Res 1987; 61: 256-70.
47. Milner P, Ralevic V, Hopwood AM, et al. Ultrastructural localisation of substance P and choline acetyltransferase in endothelial cells of rat coronary artery and release of substance P and acetylcholine during hypoxia. Experientia 1989; 45: 121-5.
48. Vanhoutte PM, Verbeuren TJ, Webb RC. Local modulation of the adrenergic neuroeffector interaction in the blood vessel wall. Physiol Rev 1981; 61: 151-247.
49. Shepherd JT, Vanhoutte PM. The Human Cardiovascular System. Facts and Concepts. English Edition: Raven Press; New York 1979; 1-351.
50. Mombouli JV, Vanhoutte PM. Kinins mediate Kallikrein-induced endothelium-dependent relaxations in isolated canine coronary arteries. Biomed Biophys Res Comm 1992; 185: 693-7.
51. Mombouli JV, Illiano S, Vanhoutte PM. Local Production of Kinins contributes to the endothelium dependent-relaxations evoked by converting enzyme inhibitors in isolated arteries. Agen Actions 1992; 38: 186-95.
52. Mombouli JV, Vanhoutte PM. Kinins and Endothelium-dependent relaxations to converting enzyme inhibitors in perfused canine arteries. J Cardiovasc Pharmacol 1991; 18: 926-7.
53. Roves P, Kurz S, Hanjörg J, et al. Role of endogenous bradykinin in human coronary vasomotor control. Circulation 1995; 92: 3424-30.
54. Mombouli JV, Vanhoutte PM. Kinins and vascular endothelium. Ann Rev Pharmacol Toxicol 1995; 35: 679-705.
55. Miller VM, Vanhoutte PM. Endothelium-dependent responses in isolated blood vessels of lower vertebrates. Blood Vessels 1986; 23: 225-35.
56. Miller VM, Vanhoutte PM. Prostaglandins but not Nitric Oxide are endothelium-derived relaxing factors in the trout aorta. Acta Pharmacologica Sinica 2000; 21: 871-6.
57. Vanhoutte PM. Say NO to ET. J Autonom Nerv Sys 2000; 81: 271-7.
58. Vidal MJ, Romero JC, Vanhoutte PM. Endothelium-derived relaxing factor inhibits renin release. Eur J Pharmacol 1988; 149: 401.
59. Auch-Schwelk W, Katusic ZS, Vanhoutte PM. Nitric oxide inactivates endothelium-derived contracting factor in the rat aorta. Hypertension 1992; 19: 442-5.
60. Cook RP. The antagonism of acetyl choline by methylene blue. J Physiol 1926; 62: 160-5.
61. Yang D, Gluais P, Zhang JN, et al. Nitric Oxide and Inactivation of the Endothelium-dependent Contracting Factors released by Acetylcholine in SHR. J Cardiovasc Pharmacol 2004; 43: 815-20.
62. Lee M, Li H, Xiao Y, et al. Chronic administration of BMS309403, an inhibitor of Adipocyte Fatty Acid-Binding Protein (A-FABP) improves endothelial function in apolipoprotein E-deficient (ApoE- /-) mice and in cultural human endothelial cells. Br J Pharmacol 2011; 162: 1564-76.
63. Liu JTC, Song E, Xu A, et al. Lipocalin-2 deficiency prevents endothelial dysfunction associated with dietary obesity: role of cytochrome P450 2C inhibition. Br J Pharmacol 2012; 165: 520-31.
64. Osto E, Doytcheva P, Corteville C, et al. Rapid and body weightindependent improvement of endothelial function and HDL properties after Roux-en-Y gastric bypass: role of glucagon-like peptide- 1. Circulation 2015; in press.
65. Shimokawa H, Flavahan NA, Vanhoutte PM. Natural Course of the impairment of endothelium-dependent relaxations after balloon endothelium- removal in porcine coronary arteries. Circ Res 1989; 65: 740-53.
66. Shimokawa H, Flavahan NA, Vanhoutte PM. Loss of endothelial pertussis toxin-sensitive G-protein function in atherosclerotic porcine coronary arteries. Circulation 1991; 83: 652-60.
67. Flavahan NA, Shimokawa H, Vanhoutte PM. Pertussis toxin inhibits endothelium-dependent relaxations to certain agonists in porcine coronary arteries. J Physiol 1989; 408: 549-60.
68. Vanhoutte PM, Tang E, Félétou M, Shimokawa H. Endothelial dysfunction and vascular disease. Acta Physiol 2009; 196: 193-222.
69. Ge T, Hughes H, Junquero DC, et al. Endothelium-Dependent contractions are associated with both augmented expression of prostaglandin H synthase-1 and hypersensitivity to prostaglandin H2 in the SHR aorta. Circ Res 1995; 76: 1003-10.
70. Ge T, Vanhoutte PM, Boulanger CM. Increased response to Prostaglandin H2 precedes changes in PGF-synthase 1 expression in the SHR aorta. Acta Pharmacologica Sinica 1999; 20: 1087-92.
71. Taddei S, Virdis A, Ghiadoni L, et al. Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension. Hypertension 1997; 29: 274-9.
72. Taddei S, Virdis A, Ghiadoni L, et al. Endothelium, aging, and hypertension. Curr Hypertens Rep 2006; 8: 84-9.
73. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-26.
74. Aikawa M, Libby P. The vulnerable atherosclerotic plaque. Pathogenesis and therapeutic approach. Cardiovasc Path 2004; 13: 125-38.
75. Tang EHC, Feletou M, Huang Y, et al. Acetylcholine and Sodium Nitroprusside Cause Long-Term Inhibition of EDCF-Mediated Contraction. Am J Physiol 2005; 289: H2434-40.
76. Olmos L, Mombouli JV, Illiano S, et al. cGMP mediates the desensitization to bradykinin in isolated canine coronary arteries. Am J Physiol 1995; 268: H865-70.
77. Thollon C, Bidouard JP, Cambarrat C, et al. Alteration of endothelium- dependent hyperpolarizations in porcine coronary arteries with regenerated endothelium. Circ Res 1999; 84: 371-7.
78. Thollon C, Fournet-Bourguignon MP, Saboureau D, et al. Consequences of reduced production of NO on vascular reactivity of porcine coronary arteries after angioplasty: importance of EDHF. Br J Pharmacol 2002; 136: 1153-61.
79. De Mey JGR, Vanhoutte PM. End O' the line revisited: moving on from nitric oxide to CGRP. Life Sci 2015; in press.
80. Borg-Capra C, Fournet-Bourguignon MP, Janiak P, et al. Morphological heterogeneity with normal expression but altered function of G proteins in cultured regenerated porcine coronary endothelial cells. Br J Pharmacol 1997; 122: 999-1008.
81. Fournet-Bourguignon MP, Castedo-Delrieu M, Bidouard JP, et al. Phenotopic and functional changes in regenerated porcine coronary endothelial cells. Increased uptake of modified LDL and reduced production of NO. Circ Res 2000; 86: 854-61.
82. Lee MYK, Tse HF, Siu CW, et al. Genomic changes in regenerated porcine coronary arterial endothelial cells. Arterioscler Thrombos Vasc Biol 2007; 27: 2443-49.
83. Lee MYK, Wang Y, Vanhoutte P. Senescence of cultured porcine coronary arterial endothelial cells is associated with accelerated oxidative stress and activation of NFκB. J Vascular Res 2010; 47: 287-98.
84. Chan C, Zhao Y, Liao SY, et al. A-FABP and oxidative stress underlie the impairment of endothelium-dependent relaxations to serotonin and the intima-medial thickening in the porcine coronary artery with regenerated endothelium. ACS Chem Neurosci 2013; 4: 122-9.
85. Vanhoutte PM. Effects of anoxia and glucose depletion on isolated veins of the dog. Am J Physiol 1976; 230: 1261-8.
86. Van Nueten JM, Vanhoutte PM. Effect of the Ca2+ antagonist lidoflazine on normoxic and anoxic contractions of canine coronary arterial smooth muscle. Eur J Pharmacol 1980; 64: 173-6.
87. Rubanyi GM, Vanhoutte PM. Hypoxia releases a vasoconstrictor substance from the canine vascular endothelium. J Physiol 1985; 364: 45-56.
88. Vanhoutte PM, Auch-Schwelk W, Boulanger C, et al. Does endothelin- 1 mediate endothelium-dependent contractions during anoxia? J Cardiovasc Pharmacol 1989; 13: 124-8.
89. Pearson PJ, Lin PJ, Schaff HV, et al. Augmented endotheliumdependent constriction to hypoxia early and late following reperfusion of the canine coronary artery. Clin Exp Pharmacol Physiol 1996; 23: 634-41.
90. 1. Biol Chem 2013; 394: 261-70.
91. Chen Z, Zhang X, Ying L, et al. Cyclic IMP-synthesized by sGC as a mediator of hypoxic contraction of coronary arteries. Am J Physiol 2014; 307: H328-36.